ABSTRACT Chimeric bacterial genes conferring resistance to aminoglycoside antibiotics have been inserted into the Agrobacterium tumefaciens tumor-inducing (Ti) plasmid and introduced into plant cells by in vitro transformation techniques. The chimeric genes contain the nopaline synthase 5' and 3' regulatory regions joined to the genes for neomycin phosphotransferase type I or type II. The chimeric genes were cloned into an intermediate vector, pMON120, and inserted into pTiB6S3 by recombination and then introduced into petunia and tobacco cells by cocultivating A. tumefaciens cells with protoplast-derived cells. Southern hybridization was used to confirm the presence of the chimeric genes in the transformed plant tissues. Expression of the chimeric genes was determined by the ability of the transformed cells to proliferate on medium containing normally inhibitory levels of kanamycin (50 ,jg/ml) or other aminoglycoside antibiotics. Plant cells transformed by wild-type pTiB6S3 or derivatives carrying the bacterial neomycin phosphotransferase genes with their own promoters failed to grow under these conditions. The significance of these results for plant genetic engineering is discussed.
The transformation of plant cells by virulent strains of Agrobacterium tumefaciens has been studied extensively by several laboratories (1) (2) (3) (4) . A small fragment of the tumor-inducing (Ti) plasmid, called transferred DNA (T-DNA), is known to be transferred to and stably incorporated in the nuclear DNA of transformed plant cells (5) (6) (7) . The T-DNA is actively transcribed in plant cells (8) (9) (10) and specific gene products have been shown to be responsible for the observed phytohormoneindependent growth characteristics (11, 12) and novel metabolic capacities (13) exhibited by crown gall tumor cells. The transfer and insertion of T-DNA into plant DNA is thought to involve repeated nucleotide sequences present near the T-DNA "borders" (14, 15) as well as other genes of unknown function located in specific virulence regions outside of T-DNA (16, 17) .
In spite of our considerable understanding of the A. tumefaciens-Ti plasmid system, several problems remain which limit its use as a vector for genetically modifying higher plants. Because of the high levels of phytohormones produced by crown gall tumor cells (18) they have generally proven recalcitrant to attempts to induce regeneration into whole plants (19, 20) . Exceptions to this are cases in which, as a result of aberrant integration or spontaneous deletion events, transformed cells have lost all or part of the Ti plasmid tumor genes and can now be regenerated (21, 22) . In addition, transformation of cells by weakly virulent, mutant Ti plasmids (23) and transformation by root-inducing (Ri) plasmids (24, 25) have been shown to produce callus that can be regenerated into whole plants. However, these plants often display morphological aberrations and may retain certain tumorous properties (26) . Another obstacle has been the failure to obtain expression from a variety of foreign genes that have been introduced into plants (23, 27 M13 replicative form DNAs were purified by using either a Triton-X-100/CsCl procedure (28) or a large-scale alkaline lysis procedure (29) , followed by purification on hydroxylapatite (30) . DNA fragments were isolated by electroelution into dialysis bags after polyacrylamide gel electrophoresis and band excision or by adsorption onto NA-45 DEAE membrane (Schleicher & Schuell) after agarose gel electrophoresis (31) .
The BamHI synthetic DNA linkers (5' C-C-G-G-A-T-C-C-G-G) were purchased from Collaborative Research (Waltham, MA). Other synthetic DNAs were synthesized by using a modification of the phosphite procedure (32) .
Enzymes. All restriction endonucleases and the large Klenow fragment of DNA polymerase I were obtained from New England Biolabs or Bethesda Research Laboratories and were used according to the instructions of the supplier. Phage T4 DNA ligase was prepared as in ref. 33 . DNA fragment assembly was carried out as described (31) .
Transformation of Escherichia coli Cells. Plasmid DNAs were introduced into E. coli cells by using CaCl2-treated or RuCl2-treated cells (31) . The recipient E. coli K-12 strains were SR200 = C600 thr pro recA56 hsdR(r-m+) (34); LE392 = ED8554 hsdR (r-m+) (31) ; SR20 = GM42 = his dam-3 (35) ; and the M13 Abbreviations: bp, base pair(s); kb, kilobase(s); NPTase I and NPTase II, neomycin phosphotransferase, types I and II, respectively; Ti plasmid, tumor-inducing plasmid; T-DNA, transferred DNA; Ri plasmid, rootinducing plasmid. 4803 The publication costs of this article were defrayed in part by page charge payment. This article must therefore be herebv marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. phage host, JM101 (36) . Cells carrying recombinant plasmids were selected or grown (or both) on Luria medium plates or broth at 370C containing appropriate antibiotics (ampicillin, 200 gg/ml; spectinomycin, 50 pg/ml; and kanamycin, 40 ,ug/ml).
Introduction of pMON120 Derivatives into A. tumefaciens. Plasmid pMON120 or its derivatives were transferred to a chloramhpenicol-resistant A. tumefaciens strain GV3111 = C58CI CmR canying pTiB6S3trac (37) by using a triparental plate mating procedure (ref. 38 ; R. Riedel, personal communication). Briefly, 0.2 ml of a fresh overnight culture of LE392 carrying pMON120 or its derivative was mixed with 0.2 ml of an overnight culture of HB101 (31) carrying the pRK2013 (38) plasmid and 0.2 ml of an overnight culture of GV3111 cells. The mixture of cells was spread on an LB plate and incubated for 16-24 hr at 300C to allow plasmid transfer and recombination. The cells were resuspended in 3 ml of 10 mM MgSO4 and a 0.2-ml aliquot was then spread on an LB plate containing 25 ,g of chloramphenicol per ml and 100 ,ug each of spectinomycin and streptomycin per ml to select A. tumefaciens carrying the pMON120 derivatives. After incubation for 48 hr at 300C, =10 colonies per plate were obtained. Control matings between HB101/pRK2013 cells and GV3111 cells never gave rise to colonies after this selection. Typically, one colony was chosen and grown at 30°C in LB medium containing chloramphenicol, spectinomycin, and streptomycin at the same concentrations given above.
Protoplast Isolation and Culture. "Mitchell" petunia plants were grown in environmental chambers under fluorescent and incandescent illumination (=5,000 lux, 12 hr/day) at 210C in a 50:50 mixture of vermiculite and Pro-mix BX (Premier Brands, Quebec, PQ, Canada). Leaves were surface sterilized, cut into 2-mm strips, and enzymatically digested as described (39) . The resultingprotoplasts were purified by passage through stainless steel meshes and by density floatation as described (39) Cocultivation of A tumefaciens Cells with Plant Protoplasts.
On day 2 after protoplast isolation, aliquots (10-50 ju) of an overnight culture of A. tumefaciens cells were added to each flask (final bacterial cell density = 108 cells per ml) and cocultivation with plant cells was carried out for 24-30 hr essentially as described (40) . On day 3, 6 ml of culture medium (lacking phytohormones and mannitol) containing carbenicillin (1.5 mg/ml) was added to each flask (final concentration = 500,Lg/ ml) to prevent further bacterial growth. On day 4, an additional 6 ml of the above medium (containing carbenicillin at 500 ug/ ml) was added. On day 6, 0.5 ml of the cell mixture was transferred to and spread in a thin layer on the surface of doublefilter feeder plates (41) . These consisted of agar medium (MS salts, B-5 vitamins, 3% sucrose, 3% mannitol, 0.1 ug of indole acetic acid per ml, and 500 pg of carbenicillin per ml at pH 5.7), a layer of Nicotinia tabacum suspension cells, a tight fitting 8.5-cm Whatman filter paper disc (guard disc), and a 7.0-cm Whatman filter paper disc (transfer disc). After 7-10 days, microcolonies (-0.5 mm) were observable on the feeder plates and the transfer disc was removed and placed on selection medium (MS salts, B-S vitamins, 3% sucrose, 500 jig of carbenicillin per ml at pH 5.7) lacking phytohormones. 1010 Bq) for the unlabeled arginine in the assay buffer. The conditions for electrophoresis were as described (42) and the resulting electrophoretograms were exposed to x-ray film (Kodak, for [16] [17] [18] [19] [20] [21] [22] [23] [24] hr. The positions of octopine, nopaline, and arginine were established by their comigration with authentic standards.
Callus for NPTase assays were frozen in liquid N2 and extracted by using a mortar and pestle in a minimal volume of buffer (0.2 M Tris.HCI/2 mM EDTA/7.5% polyvinylpolypyrrolidone). The crude extract was clarified by centrifugation (Eppendorf; Brinkmann) and assays were performed as described (43) .
RESULTS
NPTase coding sequences were used in the initial chimeric gene constructions described in this study becue plant cells were determined to be sensitive to various aminoglycoside antibiotics (unpublished data), and the expression of NPTase in yeast (43) and mammalian cells (44, 45) has been previously shown to confer resistance to the antiobiotic, G418. The nopaline synthase gene promoter and 3'-nontranslated regions were selected because this gene has been well characterized (9, 46) and it is known to be expressed constitutively in most plant tissues transformed with the A. tunmfaciens Ti plasmid (47) .
Construction of Chimeric Genes. The nopaline synthase promoter region, obtained on a 350-base-pair (bp) Sau3A fragment from the HindIII-23 fragment of pTiT37 ( Fig. 1; ref. 46 ), was engineered to remove the entire nopaline synthase coding sequence. The resulting promoter fragment that extends from base -264 to base 35 of the nopaline synthase sequence (46) was positioned next to the Bgl II site located just outside the NPTase II coding sequence (49) . In addition, a 260-bp Mbo I fragment, extending from base 1,297 to base 1,554 of the published nopaline synthase sequence (46) , was isolated from the HindIII-23 fragment. This Mbo I fragment contains the nopaline synthase 3'-nontranslated region and polyadenylylation site. This fragment was ligated together with the EcoRI-BamHI fragment that contained the nopaline synthase promoter and NPTase II structural gene to yield the intact chimeric gene on a 1.5-kilobase (kb) EcoRI fragment (Fig. 1) . A second chimeric gene, containing the nopaline synthase promoter and 3'-nontranslated region joined to the NPTase I coding sequence (Fig.  2) , was constructed in a similar fashion. As controls, plasmids were constructed that contained an intact NPTase II promoter and structural sequence with the nopaline synthase 3'-nontranslated region (pMON139 and pMON140; Fig. 2) .
Introduction of Chimeric Genes into the Ti Plasmid. The vector pMON120 used for the transfer of the chimeric genes into A. tumefaciens cells is shown in Fig. 2 (46) , and a 308-bp promoter fragment was obtained after digestion with EcoRI. The flush-end of the promoter fragment was joined to a 1-kb Bgl II-BamHI fragment carrying the NPTase II coding sequence (a BamHI linker had been inserted at the Sma I site) at the filled-in Bgl II site (49) . This fusion regenerates the Bgl II site. The chimeric gene was completed by the addition of a 260-bp Mbo I fragment that contained the nopaline synthase 3'-nontranslated region. This fragment, which contains a polyadenylylation signal (46) , was converted to a flush-ended fragment with Klenow polymerase and cloned into the Sma I site of a M13 mp8 (50) (Fig. 3) (51), a 2.2-kb partial Cla I to Pvu I fragment of pTiT37 DNA that encodes an intact nopaline synthase (NOS) gene, a 2.7-kb Cla I-EcoRI fragment of Tn7 (37) DNA carrying the determinant for spectinomycin/streptomycin resistance, and the 1.6-kb HindII-Bgl II fragment from the HindIII18c fragment of the pTiA6 plasmid. This T-DNA fragment is known to specify two transcripts that are not essential for tumorous growth (8, 12) . At the bottom are three chimeric genes inserted at the unique EcoRI site of pMON120. The chimeric nopaline synthase-NPTase II-nopaline synthase gene was inserted to give pMON129 and pMON128. In all of these examples, the first plasmid carries the inserted gene as it is drawn in the figure. The second plasmid carries the insert in the opposite orientation to that drawn. Plasmids pMON131 and pMON130 carry a chimeric nopaline synthase-NPTase I-nopaline synthase gene. The final chimeric gene is carried in plasmids pMON140 and pMON139. The bacterial NPTase II promoter and coding sequence have beenjoined to the nopaline synthase 3'-nontranslated region.
formants, and the control NPTase II-NPTase II-nopaline synthase construct in pMON139 and pMON140 transformants (Fig.  3a) .
Similar results were obtained for pMON130 and pMON131 transformants, which contain the chimeric nopaline synthaseNPTase I-nopaline synthase gene on a 1.5-kb EcoRI fragment (Fig. 3b) . No hybridization with either the Tn5-or Tn601-specific probe was detected in transformants containing only the pMON120 vector. Other minor bands of hybridization are present in the pMON129 and pMON140 transformants; these may be attributable to partial digestion or aberrant integration events and their assignment awaits further analysis of clonal tissue. Blot hybridization analysis of DNA from these transformants using T-DNA-specific probes confirmed the presence of the expected internal T-DNA fragments in the transformed tissues and ruled out any possibility that the plant tissue was contaminated by A. tumefaciens cells (data not shown).
Other transformed, hormone-independent calli from these experiments were transferred to agar medium containing kana- mycin (50 ,ug/ml) and these were scored after 2-3 wk for resistance to the antibiotic. All transformants obtained from experiments utilizing pMON120, pMON139, or pMON140 failed to grow on medium supplemented with kanamycin, whereas all the transformants from experiments utilizing pMON128, pMON129, pMON130, or pMON131 grew on medium containing the antibiotic at rates comparable to growth on normal medium. A quantitative assessment of the level of resistance conferred by the chimeric genes is shown for pMON120, Kanamycin, ,ug/ml pMON129, and pMON131 (Fig. 4) . The results are based on the net growth of independent transform-ants on medium containing the levels of antibiotic shown in the figure, compared to growth in the absence of antibiotics. It is apparent that transformants containing the chimeric nopaline synthase-NPTase IInopaline synthase gene (pMON129) require =20-fold higher levels of kanamycin to depress net growth by 50% in comparison to transformants lacking the chimeric gene (pMON120). Similar results were obtained for pMON128, which contains. the chimeric gene in the opposite orientation in the pMON120 vector (not shown). Transformants containing pMON139 and pMON140 have dose responses identical to pMON120. Transformants containing pMON130 or pMON131 (chimeric nopaline synthase-NPTase I-nopaline synthase gene) are less resistant to kanamycin than those containing pMON128 or pMON129 (results shown for pMON130). However, this level of resistance (==3-fold greater than control cells) is still quite adequate for selection (see below).
Additional cocultivation experiments were carried out without hormone-independent selection (i.e., medium supplemented with phytohormones which support the growth of nontransformed cells). The resulting microcolonies (==1 mm) were transferred to phytohormone-supplemented medium containing kanamycin (50 ttg/ml) and within 2-3 wk, growing colonies were readily observable on plates containing cells that were transformed with pMON128, pMON129, pMON130, or pMON131. The frequency of transformation obtained by using antibiotic selection was comparable to that obtained by using hormone-independent selection. Opine (data not shown) and Southern hybridization analysis (Fig. 3a, lanes 7 and 8; Fig.  3b , lanes 5 and 6) of the kanamycin-resistant colonies confirmed that they were indeed transformants. No 
